Polymorphisms Within the RET Proto-Oncogene and Risk of Sporadic Medullary Thyroid Carcinoma-Reference-Cited by-同舟云学术

Polymorphisms Within the RET Proto-Oncogene and Risk of Sporadic Medullary Thyroid Carcinoma

Published:2020-11-01 Issue:11 Volume:30 Page:1579-1588
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Gemignani Federica¹,Romei Cristina²,Ciampi Raffaele²,Corrado Alda¹,Melaiu Ombretta¹,Figlioli Gisella³,Bonotti Alessandra⁴,Foddis Rudy⁴,Cristaudo Alfonso⁴,Pellegrini Giovanni⁵,Vivaldi Agnese⁵,Cipollini Monica¹,Landi Stefano¹,Elisei Rossella²

Affiliation:

1. Department of Biology, University of Pisa, Pisa, Italy.

2. Endocrine Unit, Department of Clinical and Experimental Medicine, University Hospital of Cisanello, Pisa, Italy.

3. IFOM, The FIRC Institute of Molecular Oncology, Milano, Italy.

4. Department of Translational Research and New Technologies in Medicine and Surgery, Hospital of Cisanello, Pisa, Italy.

5. Operative Unit of Laboratory of Clinical Chemistry Analyses, University Hospital of Cisanello, Pisa, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2019.0352

Reference31 articles.

1. Medullary thyroid carcinoma

2. A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma

3. Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma

4. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients

5. Częstość występowania mutacji somatycznych RAS w raku rdzeniastym tarczycy — analiza populacji polskiej

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Basis and Natural History of Medullary Thyroid Cancer: It is (Almost) All in the RET;Cancers;2023-10-05

2. Design of new drugs for medullary thyroid carcinoma;Frontiers in Oncology;2022-12-05

3. MANAGEMENT OF ENDOCRINE DISEASE: Medullary thyroid cancer: from molecular biology and therapeutic pitfalls to future targeted treatment perspectives;European Journal of Endocrinology;2022-09-01

4. Modifier Role of Common RET Variants in Sporadic Medullary Thyroid Carcinoma;International Journal of Molecular Sciences;2021-10-30